{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:48:00Z","timestamp":1792140480581,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS116400"],"award-info":[{"award-number":["R01NS116400"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS114218"],"award-info":[{"award-number":["R01NS114218"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS102451"],"award-info":[{"award-number":["R01NS102451"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF-2019-12,370,334"],"award-info":[{"award-number":["RF-2019-12,370,334"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["PNRR-POC-2023-12,377,653"],"award-info":[{"award-number":["PNRR-POC-2023-12,377,653"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.nbd.2025.106849","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:28:06Z","timestamp":1740396486000},"page":"106849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy"],"prefix":"10.1016","volume":"207","author":[{"given":"Amber","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"di Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xhesika","family":"Kolici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106849_bb0005","article-title":"Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease?","volume":"140","author":"Abati","year":"2020"},{"key":"10.1016\/j.nbd.2025.106849_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108719","article-title":"Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration","volume":"196","author":"Andersen","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2025.106849_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1523\/JNEUROSCI.3237-07.2008","article-title":"Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse","volume":"28","author":"Biondi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106849_bb0020","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.1764-10.2010","article-title":"In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice","volume":"30","author":"Biondi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106849_bb0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eplepsyres.2007.03.002","article-title":"Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet","volume":"74","author":"Bough","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2025.106849_bb0030","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1523\/JNEUROSCI.2728-12.2013","article-title":"Shift from extracellular signal-regulated kinase to AKT\/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells","volume":"33","author":"Branchu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106849_bb0035","series-title":"Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models","first-page":"24","author":"Buettner","year":"2021"},{"key":"10.1016\/j.nbd.2025.106849_bb0040","article-title":"Stasimon\/Tmem41b is required for cell proliferation and adult mouse survival","volume":"712","author":"Carlini","year":"2024"},{"key":"10.1016\/j.nbd.2025.106849_bb0045","series-title":"Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine","first-page":"2","author":"Chaytow","year":"2021"},{"key":"10.1016\/j.nbd.2025.106849_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s13023-021-02065-z","article-title":"Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis","volume":"16","author":"Coratti","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2025.106849_bb0055","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s11064-020-03014-1","article-title":"D-serine, the shape-shifting NMDA receptor co-agonist","volume":"45","author":"Coyle","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2025.106849_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.1960.tb13458.x","article-title":"The excitation and depression of spinal neurones by structurally related amino acids","volume":"6","author":"Curtis","year":"1960","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.106849_bb0065","series-title":"Specialized astrocytes mediate glutamatergic gliotransmission in the CNS","first-page":"120","volume":"622","author":"de Ceglia","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0070","series-title":"D-amino acids: new clinical pathways for brain diseases","author":"de Oliveira Souza","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115913","article-title":"Metabolic dysfunction in spinal muscular atrophy","volume":"22","author":"Deguise","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106849_bb0080","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1093\/brain\/awad221","article-title":"Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy","volume":"146","author":"Delestr\u00e9e","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106849_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106203","article-title":"Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson\u2019s disease patients","volume":"184","author":"Di Maio","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106849_bb0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuint.2013.06.015","article-title":"Astrocytic energetics during excitatory neurotransmission: what are contributions of glutamate oxidation and glycolysis?","volume":"63","author":"Dienel","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2025.106849_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2025.106849_bb0100","article-title":"New insights on the influence of free d-aspartate metabolism in the mammalian brain during prenatal and postnatal life","volume":"1868","author":"Errico","year":"2020"},{"key":"10.1016\/j.nbd.2025.106849_bb0105","series-title":"Nusinersen induces disease-severity-specific neurometabolic effects in spinal muscular atrophy","first-page":"1431","volume":"12","author":"Errico","year":"2022"},{"key":"10.1016\/j.nbd.2025.106849_bb0110","series-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","first-page":"1723","volume":"377","author":"Finkel","year":"2017"},{"key":"10.1016\/j.nbd.2025.106849_bb0115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nn.4561","article-title":"Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy","volume":"20","author":"Fletcher","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.106849_bb0120","article-title":"Synaptic imbalance and increased inhibition impair motor function in SMA","author":"Fletcher","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2025.106849_bb0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.20977","article-title":"D-serine in the developing human central nervous system","volume":"60","author":"Fuchs","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106849_bb0130","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1172\/JCI57549","article-title":"Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1","volume":"121","author":"Garofalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.106849_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The children\u2019s hospital of Philadelphia infant test of neuromuscular disorders (CHOP INTEND): test development and reliability","volume":"20","author":"Glanzman","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2025.106849_bb0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/PEP.0b013e3182351f04","article-title":"Validation of the children\u2019s hospital of Philadelphia infant test of neuromuscular disorders (CHOP INTEND)","volume":"23","author":"Glanzman","year":"2011","journal-title":"Pediatr. Phys. Ther."},{"key":"10.1016\/j.nbd.2025.106849_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JND-180301","article-title":"Evaluator training and reliability for SMA global Nusinersen Trials1","volume":"5","author":"Glanzman","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.nbd.2025.106849_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2025.106849_bb0155","series-title":"Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","first-page":"767","volume":"29","author":"Hashimoto","year":"2005"},{"key":"10.1016\/j.nbd.2025.106849_bb0160","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2009.01.002","article-title":"Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine","volume":"65","author":"Hashimoto","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106849_bb0165","series-title":"Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMA","first-page":"1580","volume":"7","author":"Hernandez-Gerez","year":"2020"},{"key":"10.1016\/j.nbd.2025.106849_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106413","article-title":"Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson\u2019s disease","volume":"192","author":"Imarisio","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106849_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41398-024-02991-z","article-title":"Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects","volume":"14","author":"Imarisio","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106849_bb0180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2012.09.011","article-title":"SMN is required for sensory-motor circuit function in Drosophila","volume":"151","author":"Imlach","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106849_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb6871","article-title":"Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA","volume":"13","author":"Kong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2025.106849_bb0190","series-title":"SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","first-page":"845","volume":"14","author":"Le","year":"2005"},{"key":"10.1016\/j.nbd.2025.106849_bb0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106849_bb0200","series-title":"Induction of survival of motor neuron (SMN) protein deficiency in spinal astrocytes by small interfering RNA as an in vitro model of spinal muscular atrophy","first-page":"558","volume":"11","author":"Leo","year":"2022"},{"key":"10.1016\/j.nbd.2025.106849_bb0205","series-title":"Amyotroph Lateral Scler Frontotemporal Degener","first-page":"107","article-title":"Phase I clinical trial of safety of L-serine for ALS patients","volume":"18","author":"Levine","year":"2017"},{"key":"10.1016\/j.nbd.2025.106849_bb0210","series-title":"An overview of the therapeutic strategies for the treatment of spinal muscular atrophy","first-page":"180","volume":"34","author":"Li","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011703","article-title":"Identification of the rheumatoid arthritis shared epitope binding site on calreticulin","volume":"5","author":"Ling","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.106849_bb0220","series-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","first-page":"198","volume":"8","author":"Liu","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2012.09.012","article-title":"An SMN-dependent U12 splicing event essential for motor circuit function","volume":"151","author":"Lotti","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.106849_bb0230","series-title":"Excitatory amino acid transporters in physiology and disorders of the central nervous system","first-page":"5671","volume":"20","author":"Malik","year":"2019"},{"key":"10.1016\/j.nbd.2025.106849_bb0235","series-title":"Decreased motor neuron support by SMA astrocytes due to diminished MCP1 secretion","first-page":"5309","volume":"37","author":"Martin","year":"2017"},{"key":"10.1016\/j.nbd.2025.106849_bb0240","series-title":"Glutamate receptor ion channels","first-page":"282","volume":"15","author":"Mayer","year":"2005"},{"key":"10.1016\/j.nbd.2025.106849_bb0245","series-title":"Glutamate receptors at atomic resolution","first-page":"456","volume":"440","author":"Mayer","year":"2006"},{"key":"10.1016\/j.nbd.2025.106849_bb0250","article-title":"D-serine: a cross species review of safety","volume":"12","author":"Meftah","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.nbd.2025.106849_bb0255","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106849_bb0260","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy - insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2025.106849_bb0265","series-title":"Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase","first-page":"7556","volume":"107","author":"Mitchell","year":"2010"},{"key":"10.1016\/j.nbd.2025.106849_bb0270","series-title":"Diagnostic tests: how to estimate the positive predictive value","first-page":"162","volume":"2","author":"Molinaro","year":"2015"},{"key":"10.1016\/j.nbd.2025.106849_bb0275","series-title":"Vesicular uptake and exocytosis of L-aspartate is independent of sialin","first-page":"1264","volume":"27","author":"Morland","year":"2013"},{"key":"10.1016\/j.nbd.2025.106849_bb0280","series-title":"L-serine synthesis via the phosphorylated pathway in humans","first-page":"5131","volume":"77","author":"Murtas","year":"2020"},{"key":"10.1016\/j.nbd.2025.106849_bb0285","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/BF01294720","article-title":"Glycine and D-serine decrease MK-801-induced hyperactivity in mice","volume":"104","author":"Nilsson","year":"1997","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2025.106849_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511939","article-title":"Spinal muscular atrophy: the past, present, and future of diagnosis and treatment","volume":"24","author":"Nishio","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106849_bb0295","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/mp.2015.61","article-title":"Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice","volume":"21","author":"Nomura","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106849_bb0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s43856-023-00256-2","article-title":"Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients","volume":"3","author":"Nuzzo","year":"2023","journal-title":"Commun. Med. (Lond)."},{"key":"10.1016\/j.nbd.2025.106849_bb0305","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the Hammersmith functional motor scale for SMA II and III patients","volume":"17","author":"O\u2019Hagen","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nbd.2025.106849_bb0310","series-title":"Notch signaling mediates astrocyte abnormality in spinal muscular atrophy model systems","first-page":"3701","volume":"9","author":"Ohuchi","year":"2019"},{"key":"10.1016\/j.nbd.2025.106849_bb0315","article-title":"An overview of the involvement of D-serine in cognitive impairment in Normal aging and dementia","volume":"12","author":"Orzylowski","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.nbd.2025.106849_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115147","article-title":"Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy","volume":"44","author":"Pagiazitis","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106849_bb0325","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1212\/WNL.0000000000006050","article-title":"An observational study of functional abilities in infants, children, and adults with type 1 SMA","volume":"91","author":"Pane","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.106849_bb0330","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.25533","article-title":"Nusinersen in type 1 spinal muscular atrophy: twelve-month real-world data","volume":"86","author":"Pane","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.106849_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41398-021-01202-3","article-title":"Serum D-serine levels are altered in early phases of Alzheimer\u2019s disease: towards a precocious biomarker","volume":"11","author":"Piubelli","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2025.106849_bb0340","series-title":"Gene-targeting therapeutics for neurological disease: lessons learned from spinal muscular atrophy","first-page":"1","volume":"72","author":"Ravi","year":"2021"},{"key":"10.1016\/j.nbd.2025.106849_bb0345","series-title":"Curing SMA: are we there yet?","first-page":"8","volume":"30","author":"Reilly","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0350","series-title":"Astrocytes influence the severity of spinal muscular atrophy","first-page":"4094","volume":"24","author":"Rindt","year":"2015"},{"key":"10.1016\/j.nbd.2025.106849_bb0355","series-title":"d-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis","first-page":"4149","volume":"26","author":"Sasabe","year":"2007"},{"key":"10.1016\/j.nbd.2025.106849_bb0360","series-title":"Phosphorylation of a mitotic kinesin-like protein and a MAPKKK by cyclin-dependent kinases (CDKs) is involved in the transition to cytokinesis in plants","first-page":"17844","volume":"108","author":"Sasabe","year":"2011"},{"key":"10.1016\/j.nbd.2025.106849_bb0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/joa.12083","article-title":"Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?","volume":"224","author":"Shababi","year":"2014","journal-title":"J. Anat."},{"key":"10.1016\/j.nbd.2025.106849_bb0370","series-title":"Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy","first-page":"3885","volume":"29","author":"Simon","year":"2019"},{"key":"10.1016\/j.nbd.2025.106849_bb0375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.2142-20.2020","article-title":"Chronic pharmacological increase of neuronal activity improves sensory-motor dysfunction in spinal muscular atrophy mice","volume":"41","author":"Simon","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106849_bb0380","article-title":"Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy","author":"Simon","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.nbd.2025.106849_bb0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.conb.2007.02.006","article-title":"The neuroscience of remote memory","volume":"17","author":"Squire","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106849_bb0390","series-title":"Effect of chronic maternal L-Glu intake during gestation and\/or lactation on oxidative stress markers, AMPA Glu1 receptor and adenosine A1 signalling pathway from foetal and neonatal cerebellum","first-page":"181","volume":"20","author":"Tejero","year":"2024"},{"key":"10.1016\/j.nbd.2025.106849_bb0395","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy","volume":"35","author":"Tisdale","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106849_bb0400","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2025.106849_bb0405","series-title":"miR-206 reduces the severity of motor neuron degeneration in the facial nuclei of the brainstem in a mouse model of SMA","first-page":"1154","volume":"28","author":"Valsecchi","year":"2020"},{"key":"10.1016\/j.nbd.2025.106849_bb0410","series-title":"SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy","first-page":"1155","volume":"6","author":"Valsecchi","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0415","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10545-013-9592-4","article-title":"An update on serine deficiency disorders","volume":"36","author":"van der Crabben","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2025.106849_bb0420","series-title":"Interventions targeting glucocorticoid-Kr\u00fcppel-like factor 15-branched-chain amino acid signaling improve disease phenotypes in spinal muscular atrophy mice","first-page":"226","volume":"31","author":"Walter","year":"2018"},{"key":"10.1016\/j.nbd.2025.106849_bb0425","series-title":"Diminished motor neuron activity driven by abnormal astrocytic EAAT1 glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery","first-page":"1311","volume":"71","author":"Welby","year":"2023"},{"key":"10.1016\/j.nbd.2025.106849_bb0430","series-title":"Spinal muscular atrophy: in the challenge lies a solution","first-page":"306","volume":"44","author":"Wirth","year":"2021"},{"key":"10.1016\/j.nbd.2025.106849_bb0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","article-title":"Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next","volume":"21","author":"Wirth","year":"2020","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.nbd.2025.106849_bb0440","series-title":"The serine shuttle between glia and neurons: implications for neurotransmission and neurodegeneration","first-page":"1546","volume":"41","author":"Wolosker","year":"2013"},{"key":"10.1016\/j.nbd.2025.106849_bb0445","series-title":"Mitochondrial dysfunction in spinal muscular atrophy","first-page":"10878","volume":"23","author":"Zilio","year":"2022"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:52:00Z","timestamp":1766083920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":89,"alternative-id":["S0969996125000658"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106849","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.22.619645","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106849"}}